Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. Rilotumumab

   Amgen

   Gastric Cancer

   phase 3 · small molecule · terminated

   1 trial →

2. Rilvegostomig

   AstraZeneca

   Non-small Cell Lung Cancer

   phase 3 · small molecule · active

   1 trial →

3. Rina-S

   Genmab A/S

   Ovarian Cancer

   phase 3 · small molecule · active

   1 trial →

4. Rituximab

   The First People's Hospital of Lianyungang

   Diffuse Large B-cell Lymphoma

   phase 3 · small molecule · active

   3 trials →

5. Rituximab

   Janssen Cilag International NV

   Chronic Lymphocytic Leukemia

   phase 3 · small molecule · completed

   1 trial →

6. Rituximab

   United Therapeutics Europe Ltd

   Follicular Lymphoma

   phase 3 · small molecule · completed

   1 trial →

7. Rituximab (RTX)

   Incyte

   Diffuse Large B-cell Lymphoma

   phase 3 · small molecule · completed

   1 trial →

8. Rituximab 375 mg/m^2

   Takeda

   Mantle Cell Lymphoma

   phase 3 · small molecule · completed

   1 trial →

9. Robotic Gastrectomy

   The First People's Hospital of Lianyungang

   Gastric Cancer (GC)

   phase 3 · other · active

   1 trial →

10. Ropivacaine HCL

    Atrium Therapeutics

    Renal Carcinoma

    phase 3 · small molecule · active

    1 trial →

11. Roux-en-Y anastomosis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    phase 3 · other · active

    1 trial →

12. Rucaparib

    pharmaand GmbH

    Ovarian Cancer

    phase 3 · small molecule · completed

    1 trial →

13. S-1 therapy

    The First People's Hospital of Lianyungang

    Carcinoma, Non-Small-Cell Lung

    phase 3 · small molecule · active

    1 trial →

14. SB27-3004

    Samsung Bioepis NL B.V.

    Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

15. SBI-0145-304

    Secura Bio Limited

    relapsed/refractory nodal T cell lymphoma with T follicular helper (TFH) phenotype, relapsed/refractory nodal T cell lymphoma with T follicular helper (TFH) phenotype

    phase 3 · small molecule · active

    1 trial →

16. SBRT

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 3 · other · active

    3 trials →

17. SELINEXOR for endometrial cancer

    Karyopharm Therapeutics Inc

    endometrial cancer

    phase 3 · small molecule · active

    1 trial →

18. SGM-101

    BRIGHT MINDS BIOSCIENCES INC.

    Rectal Cancer

    phase 3 · small molecule · active

    1 trial →

19. SHR-3680-III-HSPC

    Lacuna Pharma Pty Ltd

    Metastatic hormone-sensitive prostate cancer with high tumor load

    phase 3 · small molecule · active

    1 trial →

20. SHR-A2009 ; Aumolertinib

    Suzhou Ribo Life Science Co.

    Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

21. SHR3162-III-305

    Lacuna Pharma Pty Ltd

    Metastatic Castration-Resistant Prostate Cancer

    phase 3 · small molecule · active

    1 trial →

22. SL-B2022-793-01

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    phase 3 · small molecule · active

    1 trial →

23. SMT112-3003

    Summit Therapeutics

    Metastatic Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

24. SMT112-3003

    Summit Therapeutics

    Metastatic Squamous Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

25. SMT112-3005

    Summit Therapeutics

    Metastatic colorectal cancer

    phase 3 · small molecule · active

    1 trial →

26. SMX 22-002

    Lacuna Pharma Pty Ltd

    Locally advanced or metastatic breast cancer

    phase 3 · small molecule · active

    1 trial →

27. SODIUM CHLORIDE, ROPIVACAINE

    Pari Pharma GmbH

    Cancer surgery

    phase 3 · small molecule · active

    1 trial →

28. SOLO 1-D0818C00001

    AstraZeneca AB

    BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer

    phase 3 · small molecule · active

    1 trial →

29. SPI-BEL-301

    Lacuna Pharma Pty Ltd

    Peripheral T-Cell Lymphoma

    phase 3 · small molecule · active

    1 trial →

30. SP_MH19PRO

    AXIM BIOTECHNOLOGIES, INC.

    Acute myeloid leukemia

    phase 3 · small molecule · active

    1 trial →

31. SR-A + Epratuzumab

    United Therapeutics Europe Ltd

    Acute Lymphoblastic Leukemia (ALL)

    phase 3 · small molecule · completed

    1 trial →

32. SSGJ-707

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

33. STAR-221

    Arcus Biosciences

    Metastatic Esophageal or Gastric Cancer, Esophageal or Gastric Cancer

    phase 3 · small molecule · active

    1 trial →

34. STEMNESS-CRC

    The George Institute

    Histologically confirmed adenocarcinoma of the colon or rectum that is metastatic.

    phase 3 · small molecule · active

    1 trial →

35. STEMNESS-PANC

    The George Institute

    Histologically or cytologically confirmed advanced pancreatic adenocarcinoma that is metastatic.

    phase 3 · small molecule · active

    1 trial →

36. STML-ELA-0422

    Stemline Therapeutics B.V.

    Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence

    phase 3 · small molecule · active

    1 trial →

37. SV-BR-1-GM

    BriaCell Therapeutics

    Breast Cancer

    phase 3 · mab · active

    2 trials →

38. Sacituzumab Govitecan-hziy

    Gilead Sciences Ireland UC

    Triple Negative Breast Cancer

    phase 3 · small molecule · active

    1 trial →

39. Sacituzumab tirumotecan

    Merck KGaA, Darmstadt, Germany

    Non-small Cell Lung Cancer (NSCLC)

    phase 3 · mab · active

    2 trials →

40. Sacituzumab tirumotecan

    Merck KGaA, Darmstadt, Germany

    Non Small Cell Lung Cancer

    phase 3 · mab · active

    1 trial →

41. Sacituzumab tirumotecan

    Merck KGaA, Darmstadt, Germany

    Breast Neoplasms

    phase 3 · small molecule · active

    1 trial →

42. Safe Stop

    Disc Medicine

    Melanoma

    phase 3 · small molecule · active

    1 trial →

43. Safe Stop IPI-NIVO

    Disc Medicine

    Melanoma

    phase 3 · small molecule · active

    1 trial →

44. Sasanlimab

    Pfizer Australia Pty Ltd

    Non-Muscle Invasive Bladder Cancer

    phase 3 · small molecule · active

    1 trial →

45. Savolitinib

    AstraZeneca

    Carcinoma

    phase 3 · small molecule · active

    1 trial →

46. Selinexor

    Karyopharm Therapeutics Inc

    Dedifferentiated Liposarcoma

    phase 3 · small molecule · completed

    1 trial →

47. Selinexor

    Karyopharm Therapeutics Inc

    Endometrial Cancer

    phase 3 · small molecule · active

    2 trials →

48. Selinexor (combination therapy)

    Karyopharm Therapeutics Inc

    Relapsed/Refractory Diffuse Large B-cell Lymphoma

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions